InnoCore Pharmaceuticals is the leading drug delivery development provider of long-acting injectable dosage forms of peptides and complex biologics based on its proprietary, best-in-class polymeric drug delivery platform, SynBiosys®.
SynBiosys® can overcome the significant technical challenges of translating complex and fragile APIs into stable, tunable and scalable LAI drug products whilst maintaining the essential bioactive characteristics of the API, from peptides and biologics, to oligonucleotides or antibody drug conjugates (ADC).